Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Read more about Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Read more about Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Read more about Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Read more about Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Read more about Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Read more about A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Read more about Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Metformin in Children With Relapsed or Refractory Solid Tumors Read more about Metformin in Children With Relapsed or Refractory Solid Tumors
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Read more about Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma Read more about A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma